Dachille Douglas A. — SEC Form 4 filings
SEC reporting owner CIK 1652908. 14 Form 4 filings on record with FilingPulse; latest filed 2026-07-06.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-06-25 to 2026-07-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 100 shares, $19,813 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: purchase of 100 shares @ $198.13 ($19,813) in PNC FINANCIAL SERVICES GROUP, INC., filed 2025-02-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PNC FINANCIAL SERVICES GROUP, INC. (PNC) | Director | 9 | 1 leg · 100 sh · $19,813 | — | 8 |
| BridgeBio Pharma, Inc. (BBIO) | Director | 3 | — | — | 5 |
| Equitable Holdings, Inc. (EQH) | Director | 2 | — | — | 2 |
Form 4 filings — Dachille Douglas A.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-06 | 4 | PNC FINANCIAL SERVICES GROUP, INC. (PNC) | Grant/award (A): 51 (derivative) @ $251.62 | EDGAR |
| 2026-06-24 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 3,990 @ $0 · Grant/award (A): 5,277 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | Equitable Holdings, Inc. (EQH) | Grant/award (A): 4,400 @ $42.05 | EDGAR |
| 2026-04-24 | 4 | PNC FINANCIAL SERVICES GROUP, INC. (PNC) | Grant/award (A): 844 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | PNC FINANCIAL SERVICES GROUP, INC. (PNC) | Grant/award (A): 31 (derivative) @ $209.24 | EDGAR |
| 2026-01-06 | 4 | PNC FINANCIAL SERVICES GROUP, INC. (PNC) | Grant/award (A): 31 (derivative) @ $211.46 | EDGAR |
| 2025-10-03 | 4 | PNC FINANCIAL SERVICES GROUP, INC. (PNC) | Grant/award (A): 33 (derivative) @ $198.44 | EDGAR |
| 2025-07-03 | 4 | PNC FINANCIAL SERVICES GROUP, INC. (PNC) | Grant/award (A): 66 (derivative) @ $192.52 | EDGAR |
| 2025-06-24 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 6,589 @ $0 · Grant/award (A): 8,425 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | Equitable Holdings, Inc. (EQH) | Grant/award (A): 3,393 @ $0 | EDGAR |
| 2025-04-25 | 4 | PNC FINANCIAL SERVICES GROUP, INC. (PNC) | Grant/award (A): 1,207 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | PNC FINANCIAL SERVICES GROUP, INC. (PNC) | Grant/award (A): 55 (derivative) @ $174.64 | EDGAR |
| 2025-02-05 | 4 | PNC FINANCIAL SERVICES GROUP, INC. (PNC) | Purchase (P): 100 @ $198.13 | EDGAR |
| 2024-06-25 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 26,014 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1652908 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →